Cardiovascular and Hematological Disorders - Drug Targets

Aims & Scope

Cardiovascular & Hematological Disorders-Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in cardiovascular and hematological disorders e.g. disease specific proteins, receptors, enzymes, genes.

Each issue of the journal contains a series of in-depth/mini reviews, original research articles, drug clinical trial studies and guest edited thematic issues written by leaders in the field covering a range of current topics on drug targets involved in cardiovascular and hematological disorders.

As the discovery, identification, characterization and validation of novel human drug targets for cardiovascular and hematological drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.

View Aims & Scope

---

Metrics & Ranking

SJR (SCImago Journal Rank)

Year	Value
2024	0.235

Quartile

Year	Value
2024	Q3

h-index

Year	Value
2024	46

Journal Rank

Year	Value
2024	19281

Journal Citation Indicator

Year	Value
2024	99

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology, Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Green Tea Polyphenols as an Anti-Oxidant and Anti-Inflammatory Agent for Cardiovascular Protection

  Citation: 239

  Authors: George, Tung-Ming, Ming-Wai, Man-Lung

• Renal Endothelial Dysfunction in Acute Kidney Ischemia Reperfusion Injury

  Citation: 123

  Authors: David, Mervin

• Reactive Oxygen Species in Vascular Wall

  Citation: 117

  Authors: Lai, Fung, Xiaoqiang, Zhen-Yu, Yu

• Renal Endothelial Dysfunction in Diabetic Nephropathy

  Citation: 112

  Authors: Huifang, Raymond

• Beyond Hemostasis: The Role of Platelets in Inflammation, Malignancy and Infection

  Citation: 111

  Authors: Archibald, Sara

• Endoplasmic Reticulum Stress as a Novel Therapeutic Target in Heart Diseases

  Citation: 106

  Authors: Ambrus, Philip, Adel, Mark, Kalman, Peter

• Oxidative Stress and Transforming Growth Factor-.β<sub>1</sub>-induced Cardiac Fibrosis

  Citation: 83

  Authors: Yudi, Yvette, Tamara, John, Paul

• Neutrophil Migration Under Normal and Sepsis Conditions

  Citation: 81

  Authors: Yelena, Minsoo

• Anti-Inflammatory Effects of Different Drugs/Agents with Antioxidant Property on Endothelial Expression of Adhesion Molecules

  Citation: 79

  Authors: Yung-Hsiang, Shing-Jong, Yuh-Lien, Po-Len, Jaw-Wen

• Na+/Ca2+ Exchange Inhibitors: A New Class of Calcium Regulators

  Citation: 79

  Authors: Takahiro, Yasuhide, Satomi, Mordecai

---